Kuwait’s Al-Sumait Prize (www.AlSumaitprize.org) for African Development today announced that Dr Ismahane Elouafi, the first Chief Scientist of the Food and Agriculture Organization (FAO) (www.FAO.org/home/en) of the United Nations has joined the Al Sumait Prize Board of Trustees.
Dr Khaled Al-Fadhel, Director General of the Kuwait Foundation for the Advancement of Sciences (KFAS) (www.KFAS.org), member and rapporteur of Al Sumait Board of Trustees, said: "we are privileged to welcome Dr. Elouafi, a distinguished scientist and a leader who has espoused passionately the improvement of the quality of life for African societies."
Dr Elouafi has been a board member of the International Food Policy Research Institute (IFPRI), the USA; the Centre for Agriculture and Bioscience International (CABI), the UK; and the Professional Development Institute, Canada. She is also a member of the Scientific Group for the 2021 UN Food Systems Summit and of the CGIAR System Management Board.
“I'm honored to join the Board of Trustees of the Al-Sumait Prize. It will be my pleasure to contribute in honoring and recognizing our heroes (both individuals or institutions) and their contributions to African development. We need to celebrate their achievements as generating HOPE can have a tremendous impact on people's wellbeing." Dr Elouafi said on accepting the invitation.
Her contributions to science and policy have been recognized with a number of prestigious awards and accolades, including the National Reward Medal by His Majesty Mohamed VI, the King of Morocco, and the Excellence in Science Award from the Global Thinkers Forum.
The Call for the 2021 Al-Sumait Prize in Health will close on 15th August 2021.
The Health category includes but is not limited to initiatives, program, and research projects in the following areas: Combating the prevalence of diseases in Africa, with a special focus on the utilization of effective frameworks and programs, to address and manage health crises such as SARS, COVID-19, and infectious zoonotic diseases; National capacity building in medical research and medical education; Upgrading and maintenance of national medical facilities; Developing national health policies and successful implementation of the outcomes.
Eligible candidates include organizations and research institutions whose initiatives and programs contributed significantly to solving health challenges in Africa, as well as outstanding researchers who are nominated by their institutions and peers.
For information about the AlSumait Prize for the 2021-Cycle of Health as well as its conditions and requirements, please visit http://www.alsumaitprize.org/nominations/
To access the Prize nomination form, please visit: https://kfas.formstack.com/forms/alsumait2021
For inquiries, please contact the Prizes Office on the following E-Mail: alsumaitprize@kfas.org.kw
Distributed by APO Group on behalf of Kuwait Foundation for the Advancement of Sciences (KFAS).
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
